About CAROGEN CORP
CaroGen Corporation is a biotechnology company focused on developing immunotherapy vaccines using its AVIDIO platform, targeting infectious diseases and immuno-oncology. The company has two candidates in late-stage pre-clinical studies and has received significant funding from NIH and DoD.
Development of RNA-based artificial virus platform (AVIDIO)Delivery of multiple transgenesInduction of broad spectrum of immune responsesPre-clinical development of immunotherapies for chronic hepatitis B and ovarian cancerCollaboration with academic institutions and government agencies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CAROGEN CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.